UroGen Pharma Stock News & Updates

[WKN: A2DTCV | Symbol: URGN]

Urogen Pharma: New Bladder Cancer Drugs Expected to Drive 69% Annual Revenue Growth

Urogen has achieved annual revenue growth since 2020. Since 2022, this has been reflected in a sustained...

Analysts' Top 5 Price Targets of August 19, 2025

Jost Werke [DE000JST4000] Hauck Aufhäuser reaffirms Buy rating and raises the price target from...

Analysts' Top 5 Price Targets of June 16, 2025

Incyte [US45337C1027]: Stifel upgrades from Hold to Buy with a price target of $107 (53% upside potential)...

  • 1